Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Fatigue 1Depression 1Brain Neoplasms 1Anxiety Disorders 1

Interventions

Cognitive Behavioral Therapy 4Psilocybin 3Therapeutics 2Oxygen 2Music Therapy 2Methods 2Waiting Lists 1Transurethral Resection of Prostate 1Touch 1Thyroidectomy 1TEMPO 1Surveys and Questionnaires 1Standard of Care 1Sertraline 1Selective Serotonin Reuptake Inhibitors 1Respiration 1Referral and Consultation 1Psychotherapy 1Pharmaceutical Preparations 1Paramedics 1Palliative Care 1Niacin 1Midazolam 1Methylphenidate 1Melatonin 1Ketamine 1Injections 1Hypnosis 1Glutamyl Aminopeptidase 1Fluoxetine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Anxiety Disorders × Methylphenidate × Clear all
NCT05474846 2025-11-06

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Recruiting
188 enrolled

Anxiety Disorders, Depression, Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡